214 related articles for article (PubMed ID: 21386967)
41. Frequency and prognostic significance of murine double minute protein-2 overexpression and p53 gene mutations in childhood acute lymphoblastic leukemia.
Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
Hematology; 2009 Dec; 14(6):335-40. PubMed ID: 19941740
[TBL] [Abstract][Full Text] [Related]
42. Impact of
Firtina S; Erbilgin Y; Hatirnaz Ng O; Karaman S; Karakas Z; Celkan TT; Gelen SA; Yildirmak Y; Ozbek U; Sayitoglu M
Scand J Clin Lab Invest; 2023 May; 83(3):187-193. PubMed ID: 37029683
[TBL] [Abstract][Full Text] [Related]
43. Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profiling.
Pishas KI; Neuhaus SJ; Clayer MT; Schreiber AW; Lawrence DM; Perugini M; Whitfield RJ; Farshid G; Manavis J; Chryssidis S; Mayo BJ; Haycox RC; Ho K; Brown MP; D'Andrea RJ; Evdokiou A; Thomas DM; Desai J; Callen DF; Neilsen PM
Cancer Res; 2014 Feb; 74(3):921-31. PubMed ID: 24336067
[TBL] [Abstract][Full Text] [Related]
44. The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases.
Stengel A; Kern W; Haferlach T; Meggendorfer M; Fasan A; Haferlach C
Leukemia; 2017 Mar; 31(3):705-711. PubMed ID: 27680515
[TBL] [Abstract][Full Text] [Related]
45. Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations.
Barekati Z; Radpour R; Kohler C; Zhang B; Toniolo P; Lenner P; Lv Q; Zheng H; Zhong XY
Hum Mol Genet; 2010 Aug; 19(15):2936-46. PubMed ID: 20466735
[TBL] [Abstract][Full Text] [Related]
46. TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens.
Kanagal-Shamanna R; Jain P; Takahashi K; Short NJ; Tang G; Issa GC; Ravandi F; Garcia-Manero G; Yin CC; Luthra R; Patel KP; Khoury JD; Montalban-Bravo G; Sasaki K; Kadia TM; Borthakur G; Konopleva M; Jain N; Garris R; Pierce S; Wierda W; Estrov Z; Cortes J; O'Brien S; Kantarjian HM; Jabbour E
Cancer; 2017 Oct; 123(19):3717-3724. PubMed ID: 28608976
[TBL] [Abstract][Full Text] [Related]
47. Aberrant DNA methylation and epigenetic inactivation of hMSH2 decrease overall survival of acute lymphoblastic leukemia patients via modulating cell cycle and apoptosis.
Wang CX; Wang X; Liu HB; Zhou ZH
Asian Pac J Cancer Prev; 2014; 15(1):355-62. PubMed ID: 24528056
[TBL] [Abstract][Full Text] [Related]
48. Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia.
Taylor KH; Pena-Hernandez KE; Davis JW; Arthur GL; Duff DJ; Shi H; Rahmatpanah FB; Sjahputera O; Caldwell CW
Cancer Res; 2007 Mar; 67(6):2617-25. PubMed ID: 17363581
[TBL] [Abstract][Full Text] [Related]
49. Prognostic role of bcl-xL and p53 in childhood acute lymphoblastic leukemia (ALL).
Addeo R; Caraglia M; Baldi A; D'Angelo V; Casale F; Crisci S; Abbruzzese A; Vincenze B; Campioni M; Di Tullio MT; Indolfi P
Cancer Biol Ther; 2005 Jan; 4(1):32-8. PubMed ID: 15684603
[TBL] [Abstract][Full Text] [Related]
50. Attenuating the abnormally high expression of AEBP1 suppresses the pathogenesis of childhood acute lymphoblastic leukemia via p53-dependent signaling pathway.
Li S; Juan CX; Feng AM; Bian HL; Liu WD; Zhang GQ; Wang CZ; Cao Q; Zhou GP
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1184-1195. PubMed ID: 30779088
[TBL] [Abstract][Full Text] [Related]
51. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
52. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
[TBL] [Abstract][Full Text] [Related]
53. A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers.
Dunwell T; Hesson L; Rauch TA; Wang L; Clark RE; Dallol A; Gentle D; Catchpoole D; Maher ER; Pfeifer GP; Latif F
Mol Cancer; 2010 Feb; 9():44. PubMed ID: 20184741
[TBL] [Abstract][Full Text] [Related]
54. Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options.
Stumpel DJ; Schneider P; van Roon EH; Boer JM; de Lorenzo P; Valsecchi MG; de Menezes RX; Pieters R; Stam RW
Blood; 2009 Dec; 114(27):5490-8. PubMed ID: 19855078
[TBL] [Abstract][Full Text] [Related]
55. Acute lymphoblastic leukemia with low hypodiploid/near triploid karyotype is a specific clinical entity and exhibits a very high TP53 mutation frequency of 93%.
Mühlbacher V; Zenger M; Schnittger S; Weissmann S; Kunze F; Kohlmann A; Bellos F; Kern W; Haferlach T; Haferlach C
Genes Chromosomes Cancer; 2014 Jun; 53(6):524-36. PubMed ID: 24619868
[TBL] [Abstract][Full Text] [Related]
56. Overexpression of MDM2 in acute childhood lymphoblastic leukemia.
Gustafsson B; Stål O; Gustafsson B
Pediatr Hematol Oncol; 1998; 15(6):519-26. PubMed ID: 9842645
[TBL] [Abstract][Full Text] [Related]
57. [The effect of TP53 mutations on the clinical outcomes of Ph-negative B-acute lymphoblastic leukemia following allogeneic hematopoietic stem cell transplantation].
Cao XY; Zhang Y; Liu DY; Zhang JP; Wei ZJ; Xiong M; Sun RJ; Lu Y; Zhou JR; Zhao YL; Ma W; Zhang W
Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):908-914. PubMed ID: 33333693
[No Abstract] [Full Text] [Related]
58. Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia.
Richter A; Roolf C; Hamed M; Gladbach YS; Sender S; Konkolefski C; Knübel G; Sekora A; Fuellen G; Vollmar B; Murua Escobar H; Junghanss C
BMC Cancer; 2019 Mar; 19(1):202. PubMed ID: 30841886
[TBL] [Abstract][Full Text] [Related]
59. Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.
Narayan G; Freddy AJ; Xie D; Liyanage H; Clark L; Kisselev S; Un Kang J; Nandula SV; McGuinn C; Subramaniyam S; Alobeid B; Satwani P; Savage D; Bhagat G; Murty VV
Genes Chromosomes Cancer; 2011 Dec; 50(12):1043-53. PubMed ID: 21960365
[TBL] [Abstract][Full Text] [Related]
60. Aberrant DNA methylation in pediatric patients with acute lymphocytic leukemia.
Garcia-Manero G; Jeha S; Daniel J; Williamson J; Albitar M; Kantarjian HM; Issa JP
Cancer; 2003 Feb; 97(3):695-702. PubMed ID: 12548613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
